Results 151 to 160 of about 34,909 (230)

Combinatorial targeting of MYC/BCL2-associated vulnerabilities in high-grade B-cell lymphoma. [PDF]

Br J Haematol
Donati G, Nicoli P, Miele F, Podini P, Dina G, Quattrini A, Amati B.   +6 more
europepmc   +1 more source

Impact of Long-Term Structured Exercise on Body Composition in an NTRK Fusion-Positive NSCLC Patient Treated With Entrectinib. [PDF]

Thorac Cancer
Avancini A, Sposito M, Adamoli G, Borsati A, Ciurnelli C, Scaglione IM, Eccher S, Toniolo L, Tregnago D, Longo L, Insolda J, Milella M, Schena F, Pilotto S, Belluomini L.   +14 more
europepmc   +1 more source

A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response in vitro. [PDF]

Dis Model Mech
Belloni D, Barozzi D, Milani G, Barbaglio F, Puthukkunnath AR, Ranghetti P, Perotta E, Musco T, Sampietro M, Ponzoni M, Scarfò L, Ghia P, Scielzo C.   +12 more
europepmc   +1 more source

Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial. [PDF]

NPJ Precis Oncol
Pivetta E, Canzonieri V, Bagnoli M, Chiodini P, Spina A, Arenare L, Lorusso D, Tasca G, Cecere SC, Ferrero A, Scognamiglio G, Basso-Valentina F, Califano D, De Cecco L, Di Lauro T, Nicoloso MS, Arcieri M, Russo D, Spessotto P, Indraccolo S, Mezzanzanica D, Perrone F, Pignata S, Baldassarre G.   +23 more
europepmc   +1 more source

Barriers to cervical cancer screening: a cross-sectional study of non-adherent Portuguese women. [PDF]

BMC Prim Care
Costa JM, Pimentel AL, Duarte I, Moreira AC, Santos JI, Nazaré I, Santos P.   +6 more
europepmc   +1 more source

Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial. [PDF]

ESMO Open
Paracchini L, Velle A, Di Gennaro P, Mannarino L, Ancona L, Lorusso D, Cecere SC, Colombo N, Beltrame L, Fagotti A, Tasca G, Piemontese M, Arenare L, Califano D, Galdiero F, Zadro R, Chiodini P, Perrone F, Biagioli E, D'Incalci M, Romualdi C, Pignata S, Marchini S.   +22 more
europepmc   +1 more source

Cancro cítrico

Plant Health Instructor, 2013
openaire   +1 more source

Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcome. [PDF]

Gut
Milardi G, Franceschini B, Camisaschi C, Puccio S, Costa G, Soldani C, Uva P, Cangelosi D, Carriero R, Lambroia L, Cammarota A, Lodetti-Zangrandi G, Malenica I, Erreni M, Montali I, Lottini T, Raggi C, Kunderfranco P, Polidoro MA, Aghemo A, Balsano R, Pressiani T, Piscuoglio S, Piscuoglio S, Di Tommaso L, Torzilli G, Rimassa L, Lugli E, Cassani B, Lleo A.   +29 more
europepmc   +1 more source

Terapias personalizadas no cancro

O presente trabalho explora a importância e os avanços das terapias personalizadas no tratamento do cancro, destacando o impacto da epigenética. As terapias personalizadas representam uma abordagem inovadora que permite adaptar tratamentos específicos para cada doente com base no seu perfil genético e epigenético, em vez de seguir as tradicionais ...
openaire   +1 more source

α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic cancer. [PDF]

Cell Death Dis
Malatesta S, Vigiano Benedetti V, Salviati E, Illi B, Manni I, Middonti E, Rampioni Vinciguerra GL, Licursi V, Troilo F, Colotti G, Cipolla L, Sabbioneda S, Perfetto L, Piaggio G, Bussolino F, Di Nicolantonio F, Campiglia P, Sommella EM, Mori M, Cencioni C, Spallotta F.   +20 more
europepmc   +1 more source